Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sponsors Drive CARs To The Next Destination: Pivotal Trials

Executive Summary

With proof of high response rates in small studies of B-cell malignancies in the rear view, sponsors focus on the next hurdles – launching potentially registrational studies in 2015, honing plans for a smooth-running manufacturing process and branching out into new indications.

You may also be interested in...



J.P. Morgan Notebook, Jan. 14: Kite, Cellectis And MannKind

Round-up of news and notes from the last presentations at the 2016 J.P. Morgan Healthcare Conference in San Francisco.

J.P. Morgan Notebook, Jan. 11: Pfizer/Allergan, Celgene, Gilead And More

Daily round-up of news and notes from the 2016 J.P. Morgan Healthcare Conference in San Francisco.

Where Does Novartis Go From Here In Oncology? A Conversation With Its Oncology, Gene Therapy Execs

Novartis may be behind other big rivals that already have immuno-oncology therapies on the market but its top R&D scientists Alessandro Riva and Usman Azam say it can leap frog to a front position using its early IO pipeline and targeted cancer drugs.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

OM003387

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel